Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

37
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
37
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

35
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
35
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.5K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

37
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
37
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.0K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

981
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
981

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Doctor I Can't 'Tee' off, but I Can Walk 18 Holes on the Golf Course"-Indicates Orthostatic Tremor.

Movement disorders clinical practice·2026
Same author

Distinct Brain Drivers and Shared Cerebello-Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Recurrent Hypothermia and Autonomic Dysfunction Secondary to Shapiro Syndrome.

Annals of clinical and translational neurology·2026
Same author

Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality.

Nature communications·2026
Same author

Time is brain: an expanded concept, not only for ischemic stroke A viewpoint of the Italian Association for Emergency Neurology (ANEU).

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Somatosensory Induced Cerebellar Responses to Peripheral Nerve Stimulation: A Time and Time-Frequency EEG Study.

Brain sciences·2026
Same journal

Correction to "Advancing Neuromodulation for Functional Movement Disorders: A Contemporary Narrative Review of Evidence, Gaps, and Future Outlook".

Movement disorders clinical practice·2026
Same journal

Efficacy of IncobotulinumtoxinA (BoNT-A) Injections in Upper Limb Task-Specific and Position-Dependent Tremors.

Movement disorders clinical practice·2026
Same journal

Health-Related Quality of Life in Children with Primary Complex Motor Stereotypies.

Movement disorders clinical practice·2026
Same journal

7 T MRI Connectivity-Guided Reprogramming Improves Deep Brain Stimulation Motor Outcome in Parkinson's Disease.

Movement disorders clinical practice·2026
Same journal

Cutis Verticis Gyrata in SPG11-Related Hereditary Spastic Paraplegia: A Potential Novel Association.

Movement disorders clinical practice·2026
Same journal

"Familial Is Not Always Genetic: Two Brothers with Dystonia and Oculomotor Apraxia Secondary to Rh Incompatibility-Induced Kernicterus".

Movement disorders clinical practice·2026
See all related articles

Related Experiment Video

Updated: Oct 23, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Movement Disorders and Liver Disease.

Eoin Mulroy1, Francesca Baschieri2,3, Francesca Magrinelli1,4

  • 1Department of Clinical and Movement Neurosciences UCL Queen Square Institute of Neurology London United Kingdom.

Movement Disorders Clinical Practice
|August 17, 2021
PubMed
Summary
This summary is machine-generated.

Movement disorders and liver disease often coexist due to shared causes or liver dysfunction affecting the nervous system. Early diagnosis, especially excluding Wilson

Keywords:
liver diseasesmovement disorders

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.0K
Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
10:10

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

4.2K

Related Experiment Videos

Last Updated: Oct 23, 2025

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.0K
Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy
10:10

Measurement of Liver Stiffness Using Atomic Force Microscopy Coupled with Polarization Microscopy

Published on: July 20, 2022

4.2K

Area of Science:

  • Neurology
  • Hepatology
  • Toxicology

Background:

  • Co-occurrence of movement disorders and hepatic disease presents diagnostic challenges.
  • Three main scenarios link neurological and liver conditions: shared etiology, impaired hepatic clearance, and iatrogenic/toxic injury.
  • Wilson's disease is a critical, treatable differential diagnosis that must be excluded early.

Purpose of the Study:

  • To provide a structured overview of disorders presenting with both movement disorders and liver disease.
  • To guide clinicians in the diagnostic workup and management of these complex cases.
  • To highlight the importance of early Wilson's disease detection.

Main Methods:

  • Review and synthesis of existing literature on movement disorders and liver disease associations.
  • Categorization of disorders into three principal scenarios based on underlying mechanisms.
  • Discussion of clinical pearls, diagnostic workup, differential diagnoses, and treatment considerations for common disorders.

Main Results:

  • Identified three primary etiological categories for combined movement and liver disorders.
  • Emphasized the diagnostic significance of patient age, disease progression, clinical presentation, and investigations.
  • Highlighted Wilson's disease as a key treatable condition requiring prompt exclusion.

Conclusions:

  • A systematic diagnostic approach integrating clinical and investigative findings is crucial for accurate diagnosis.
  • Timely diagnosis and disease-specific therapy significantly improve patient outcomes, particularly for treatable conditions like Wilson's disease.
  • Understanding the three etiological scenarios aids in differentiating and managing complex neurological and hepatic co-morbidities.